Correlation Between IBio, Common and Sonnet Biotherapeutics

Can any of the company-specific risk be diversified away by investing in both IBio, Common and Sonnet Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IBio, Common and Sonnet Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between iBio, Common Stock and Sonnet Biotherapeutics Holdings, you can compare the effects of market volatilities on IBio, Common and Sonnet Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IBio, Common with a short position of Sonnet Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of IBio, Common and Sonnet Biotherapeutics.

Diversification Opportunities for IBio, Common and Sonnet Biotherapeutics

-0.55

Correlation Coefficient

IBio, Common  Sonnet Biotherapeutics

Excellent diversification

The 3 months correlation between IBio, and Sonnet is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding iBio, Common Stock and Sonnet Biotherapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonnet Biotherapeutics and IBio, Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iBio, Common Stock are associated (or correlated) with Sonnet Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonnet Biotherapeutics has no effect on the direction of IBio, Common i.e., IBio, Common and Sonnet Biotherapeutics go up and down completely randomly.

Pair Corralation between IBio, Common and Sonnet Biotherapeutics

Given the investment horizon of 90 days iBio, Common Stock is expected to generate 1.24 times more return on investment than Sonnet Biotherapeutics. However, IBio, Common is 1.24 times more volatile than Sonnet Biotherapeutics Holdings. It trades about 0.17 of its potential returns per unit of risk. Sonnet Biotherapeutics Holdings is currently generating about -0.01 per unit of risk. If you would invest  238.00  in iBio, Common Stock on December 28, 2024 and sell it today you would earn a total of  193.00  from holding iBio, Common Stock or generate 81.09% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

iBio, Common Stock  vs.  Sonnet Biotherapeutics Holding

iBio, Common Stock

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in iBio, Common Stock are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, IBio, Common displayed solid returns over the last few months and may actually be approaching a breakup point.

Sonnet Biotherapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Sonnet Biotherapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Sonnet Biotherapeutics is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with IBio, Common and Sonnet Biotherapeutics

The main advantage of trading using opposite IBio, Common and Sonnet Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IBio, Common position performs unexpectedly, Sonnet Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonnet Biotherapeutics will offset losses from the drop in Sonnet Biotherapeutics' long position.

The idea behind iBio, Common Stock and Sonnet Biotherapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.